|
1
|
Bueno R, Hughes E, Wagner S, Gutin AS,
Lanchbury JS, Zheng Y, Archer MA, Gustafson C, Jones JT, Rushton K,
et al: Validation of a molecular and pathological model for
five-year mortality risk in patients with early stage lung
adenocarcinoma. J Thorac Oncol. 10:67–73. 2015. View Article : Google Scholar
|
|
2
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan XX, Wong MP, Cao ZW, Li N, Wu JL, Zhou
H, Jiang XH, Liu L and Leung ELH: Apoptotic effect of a single
compound derived from natural product in Gefitinib-resistant
non-small cell lung cancer cells. Proceedings of the 105th Annual
Meeting of the American Association for Cancer Research; San Diego,
CA, USA. 74. pp. 31932014
|
|
4
|
Kim HR, Kim DJ, Kang DR, Lee JG, Lim SM,
Lee CY, Rha SY, Bae MK, Lee YJ, Kim SH, et al: Fibroblast growth
factor receptor 1 gene amplification is associated with poor
survival and cigarette smoking dosage in patients with resected
squamous cell lung cancer. J Clin Oncol. 31:731–737. 2013.
View Article : Google Scholar
|
|
5
|
Tsai JH, Donaher JL, Murphy DA, Chau S and
Yang J: Spatiotemporal regulation of epithelial-mesenchymal
transition is essential for squamous cell carcinoma metastasis.
Cancer Cell. 22:725–736. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wood SL, Pernemalm M, Crosbie PA and
Whetton AD: The role of the tumor-microenvironment in lung
cancer-metastasis and its relationship to potential therapeutic
targets. Cancer Treat Rev. 40:558–566. 2014. View Article : Google Scholar
|
|
7
|
Yang L, Li G, Zhao L, Pan F, Qiang J and
Han S: Blocking the PI3K pathway enhances the efficacy of
ALK-targeted therapy in EML4-ALK-positive nonsmall-cell lung
cancer. Tumor Biol. 35:9759–9767. 2014. View Article : Google Scholar
|
|
8
|
Gainor JF, Varghese AM, Ou SH, Kabraji S,
Awad MM, Katayama R, Pawlak A, Mino-Kenudson M, Yeap BY, Riely GJ,
et al: ALK rearrangements are mutually exclusive with mutations in
EGFR or KRAS: An analysis of 1,683 patients with non-small cell
lung cancer. Clin Cancer Res. 19:4273–4281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boeri M, Verri C, Conte D, Roz L, Modena
P, Facchinetti F, Calabrò E, Croce CM, Pastorino U and Sozzi G:
MicroRNA signatures in tissues and plasma predict development and
prognosis of computed tomography detected lung cancer. Proc Natl
Acad Sci USA. 108:3713–3718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song SJ, Poliseno L, Song MS, Ala U,
Webster K, Ng C, Beringer G, Brikbak NJ, Yuan X, Cantley LC, et al:
MicroRNA-antagonism regulates breast cancer stemness and metastasis
via TET-family-dependent chromatin remodeling. Cell. 154:311–324.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Valeri N, Braconi C, Gasparini P, Murgia
C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat
F, et al: MicroRNA-135b promotes cancer progression by acting as a
downstream effector of oncogenic pathways in colon cancer. Cancer
Cell. 25:469–483. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kohlhapp FJ, Mitra AK, Lengyel E and Peter
ME: MicroRNAs as mediators and communicators between cancer cells
and the tumor microenvironment. Oncogene. 34:5857–5868. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edelman MJ, Feliciano J, Yue B, Bejarano
P, Ioffe O, Reisman D, Hawkins D, Gai Q, Hicks D and Serrero G:
GP88 (progranulin): A novel tissue and circulating biomarker for
non-small cell lung carcinoma. Hum Pathol. 45:1893–1899. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang M, Li G, Yin J, Lin T and Zhang J:
Progranulin overexpression predicts overall survival in patients
with glioblastoma. Med Oncol. 29:2423–2431. 2012. View Article : Google Scholar
|
|
16
|
Serrero G, Hawkins DM, Yue B, Ioffe O,
Bejarano P, Phillips JT, Head JF, Elliott RL, Tkaczuk KR, Godwin
AK, et al: Progranulin (GP88) tumor tissue expression is associated
with increased risk of recurrence in breast cancer patients
diagnosed with estrogen receptor positive invasive ductal
carcinoma. Breast Cancer Res. 14:R262012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abrhale T, Brodie A, Sabnis G, Macedo L,
Tian C, Yue B and Serrero G: GP88 (PC-cell derived growth factor,
progranulin) stimulates proliferation and confers letrozole
resistance to aromatase overexpressing breast cancer cells. BMC
Cancer. 11:2312011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Demorrow S: Progranulin: A novel regulator
of gastrointestinal cancer progression. Transl Gastrointest Cancer.
2:145–151. 2013.PubMed/NCBI
|
|
19
|
Brambilla E, Travis WD, Colby TV, Corrin B
and Shimosato Y: The new World Health Organization classification
of lung tumours. Eur Respir J. 18:1059–1068. 2001. View Article : Google Scholar
|
|
20
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V and Sobin L;
International Association for the Study of Lung Cancer
International Staging Committee; Participating Institutions: The
IASLC Lung Cancer Staging Project: Proposals for the revision of
the TNM stage groupings in the forthcoming (seventh) edition of the
TNM Classification of malignant tumours. J Thorac Oncol. 2:706–714.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sartorius CA, Hanna CT, Gril B, Cruz H,
Serkova NJ, Huber KM, Kabos P, Schedin TB, Borges VF, Steeg PS and
Cittelly DM: Estrogen promotes the brain metastatic colonization of
triple negative breast cancer cells via an astrocyte-mediated
paracrine mechanism. Oncogene. 35:2881–2892. 2016. View Article : Google Scholar :
|
|
22
|
Chen Q, Sun W, Liao Y, Zeng H, Shan L, Yin
F, Wang Z, Zhou Z, Hua Y and Cai Z: Monocyte chemotactic protein-1
promotes the proliferation and invasion of osteosarcoma cells and
upregulates the expression of AKT. Mol Med Rep. 12:219–225.
2015.PubMed/NCBI
|
|
23
|
Jiang J, Yu C, Chen M, Tian S and Sun C:
Over-expression of TRIM37 promotes cell migration and metastasis in
hepatocellular carcinoma by activating Wnt/beta-catenin signaling.
Biochem Biophys Res Commun. 464:1120–1127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tangkeangsirisin W and Serrero G: GP88
(progranulin) confers fulvestrant (Faslodex, ICI 182,780)
resistance to human breast cancer cells. Adv Breast Cancer Res.
3:68–78. 2014. View Article : Google Scholar
|
|
25
|
Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ,
Wang YK, Zeng F, Zhou JH and Zhang YK: High expression of serum
miR-21 and tumor miR-200c associated with poor prognosis in
patients with lung cancer. Med Oncol. 29:618–626. 2012. View Article : Google Scholar
|
|
26
|
Zhang BC, Gao J, Wang J, Rao ZG, Wang BC
and Gao JF: Tumor-associated macrophages infiltration is associated
with peritumoral lymphangiogenesis and poor prognosis in lung
adenocarcinoma. Med Oncol. 28:1447–1452. 2011. View Article : Google Scholar
|
|
27
|
Yang T, Thakur A, Chen T, Yang L, Lei G,
Liang Y, Zhang S, Ren H and Chen M: MicroRNA-15a induces cell
apoptosis and inhibits metastasis by targeting BCL2L2 in non-small
cell lung cancer. Tumor Biol. 36:4357–4365. 2015. View Article : Google Scholar
|
|
28
|
Wu X, Liu T, Fang O, Leach LJ, Hu X and
Luo Z: miR-194 suppresses metastasis of non-small cell lung cancer
through regulating expression of BMP1 and p27kip1. Oncogene.
33:1506–1514. 2014. View Article : Google Scholar
|
|
29
|
Li Y, Zhao W, Bao P, Li C, Ma XQ, Li Y and
Chen LA: miR-339-5p inhibits cell migration and invasion in vitro
and may be associated with the tumor-node-metastasis staging and
lymph node metastasis of non-small cell lung cancer. Oncol Lett.
8:719–725. 2014.PubMed/NCBI
|
|
30
|
Almog N, Ma L, Schwager C, Brinkmann BG,
Beheshti A, Vajkoczy P, Folkman J, Hlatky L and Abdollahi A:
Consensus micro RNAs governing the switch of dormant tumors to the
fast-growing angiogenic phenotype. PLoS One. 7:e440012012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Zhao W, Bao P, Li C, Ma XQ, Li Y and
Chen LA: miR-339-5p inhibits cell migration and invasion in vitro
and may be associated with the tumor-node-metastasis staging and
lymph node metastasis of non-small cell lung cancer. Oncology Lett.
8:719–725. 2014.
|
|
32
|
Rademakers R, Eriksen JL, Baker M,
Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ,
Josephs KA, et al: Common variation in the miR-659 binding-site of
GRN is a major risk factor for TDP43-positive frontotemporal
dementia. Hum Mol Genet. 17:3631–3642. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiao J, Herl LD, Farese RV and Gao FB:
MicroRNA-29b regulates the expression level of human progranulin, a
secreted glycoprotein implicated in frontotemporal dementia. PLoS
One. 5:e105512010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tangkeangsirisin W and Serrero G: PC
cell-derived growth factor (PCDGF/GP88, progranulin) stimulates
migration, invasiveness and VEGF expression in breast cancer cells.
Carcinogenesis. 25:1587–1592. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Edelman MJ, Feliciano J, Yue B, Bejarano
P, Ioffe O, Reisman D, Hawkins D, Gai Q, Hicks D and Serrero G:
GP88 (progranulin): a novel tissue and circulating biomarker for
non-small cell lung carcinoma. Hum Pathol. 45:1893–1899. 2014.
View Article : Google Scholar : PubMed/NCBI
|
